Addiction Tox Case Conference - July 2024
-
Register
- Non-member - Tier I - Free!
- Non-member - Tier II - Free!
- Non-member - Tier III - Free!
- Non-member - Tier IV - Free!
- Member - Tier I - Free!
- Member - Tier II - Free!
- Member - Tier III - Free!
- Member - Tier IV - Free!
Novel Use of Naltrexone For Alcohol Use Disorder
Cases:
1. Use of Naltrexone and Initiation in the ED/Hospital Setting
2. "Pre-Exposure Prophylaxis" - Use of Naltrexone PRN For Individuals at Weddings or Similar Events
About The Series: The ACMT/ASAM Addiction Toxicology Case Conference webinar series discusses Addiction/Toxicology cases in an interactive fashion featuring experts from Addiction Medicine, Addiction Psychiatry, and Medical Toxicology.
This webinar is open to the public.
Continuing Education credits are now available for this activity! Click here for more info.
Timothy Wiegand, MD, DFASAM, FACMT, FAACT (Moderator)
Director of Addiction Medicine and Addiction Medicine Consults
University of Rochester Medical Center
Timothy J. Wiegand, MD, FACMT, FAACT, DFASAM is an Associate Professor of Emergency Medicine and Public Health Sciences at the University of Rochester Medical Center in Rochester New York. He is Board Certified in Medical Toxicology and Addiction Medicine and practices in Addiction Toxicology with a mix of clinical, research, teaching, and other professional work. Dr. Wiegand has served two terms on the Board of Directors for the American College of Medical Toxicology (ACMT) and he is currently serving on the Board of Directors for the American Society of Addiction Medicine (ASAM) completing a term on the Executive Counsel as Vice President of ASAM. He begins a two-year term as Treasurer of ASAM in April 2023. Dr. Wiegand founded and led the Toxicology service at URMC until 2022 when he became Director of Addiction Medicine and Director of Addiction Medicine Consults also at URMC in the Department of Emergency Medicine. Dr. Wiegand has served as Fellowship Director for the URMC Combined Addiction Medicine Fellowship and he is the Fellowship Director for the URMC Medical Toxicology fellowship expecting to formally begin once accredited, in July of 2023.
Gloria Baciewicz, MD (Moderator)
Addiction Psycharcist
Strong Recovery
Since 1986, Gloria Baciewicz has specialized in the treatment of addiction. Professor of clinical psychiatry at the University of Rochester Medical Center, she serves as an addiction psychiatrist at Strong Recovery. Dr. Baciewicz is certified in addiction medicine by the American Board of Preventive Medicine and board certified in psychiatry, with added qualifications in addiction psychiatry. Dr. Baciewicz is a co-principal investigator for the University of Rochester’s Recovery Center of Excellence.
Eve Andersen-Buescher, PMHNP-BC
Senior Psychiatric Nurse Practitioner
University of Rochester Medical Center
Eve Andersen-Buescher has been working in the mental health field since 1986, beginning as a BSN, obtaining her MSN in 1990 and her post-master’s degree in 2015. She joined Strong Recovery in 2006 and has continued her work as a PMHNP-BC in mental health and addiction since that time. She is currently the Medical Services Coordinator at Strong Recovery, a Senior Psychiatric Nurse Practitioner and Lead APP. She often presents on topics related to addiction and mental health both internally and in the community.
Evan Schwarz, MD, FACMT
Associate Professor of Emergency Medicine
University of California, Los Angeles
Dr. Schwarz attended medical school at the University of Texas Medical Branch in Galveston, Texas, before completing a residency in Emergency Medicine at the Washington University School of Medicine in Saint Louis, Missouri. After residency, he completed a fellowship in Medical Toxicology at the University of Texas Southwestern School of Medicine in Dallas, Texas, before returning to Missouri where he was an Advisory Dean and the Medical Toxicology Division Chief and Fellowship Director at Washington University. In 2023, he took a position in the Department of Emergency Medicine at the University of California Los Angeles. He is also a member of the Board of Directors for ACMT.
Richard Scott Dent, MD
Clinical Senior Instructor
University of Rochester Medical Center, Rochester, NY
Dr. Dent began his career teaching elementary and middle school for six years in Texas and California prior returning to school and then obtaining his medical degree from the University of Rochester School of Medicine and Dentistry. He completed his family medicine residency at Lancaster General Hospital in Lancaster, Pennsylvania. Dr. Dent spent his first six years after residency as a primary care physician primarily in urban practices in Rochester. He has always incorporated addiction medicine in his primary care practice. In 2018, he transitioned full time into addiction medicine work. From 2019 to 2023, he was the medical director for Chemical Dependency at Rochester Regional Health. Seeking more clinical and less administrative work, he now works and directs the smaller IMAT Clinic (Individualized Medicine for Addiction Treatment), also through Rochester Regional Health. He is originally from Rochester, and lives with his wife and 2 boys in Honeoye Falls, NY.
Continuing Education
Continuing Education credit for this activity is provided by AKH Inc., Advancing Knowledge in Healthcare, and is available for an additional fee ($20 administrative fee per certificate).
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and American College of Medical Toxicology (ACMT). AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 1.25 Interprofessional Continuing Education (IPCE) credit for learning and change.
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this live virtual activity and enduring activity material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. For physicians, hours of participation are the number of AMA PRA Category 1 Credit(s)™ awarded.
Nurses
Credit being awarded:1.25 ANCC contact hours.
Commercial Support
There is no commercial support for this activity.
Timothy J. Wiegand, MD, FACMT, DFASAM, Lead Physician Planner/Reviewer/Faculty: has nothing to disclose.
Gloria J. Baciewicz, MD, Physician Planner/Reviewer/Faculty: has nothing to disclose.
Eve Andersen-Buescher, PMHNP-BC, Faculty: has nothing to disclose.
Dorothy Caputo, MA, BSN, RN, Lead Nurse Planner/Reviewer: has nothing to disclose.
Bernadette Marie Makar, MSN, NP-C, APRN-C, Nurse Planner/Reviewer: has nothing to disclose.
AKH Planners and Reviewers: have nothing to disclose.
None of the planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All of the relevant financial relationships listed for these individuals have been mitigated.
Disclosures
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to optout@akhcme.comwith your information with "Opt Out" in the subject line.
Read Full Disclosures:
Key:
Complete
Next
Failed
Available
Locked